Echoviruses Bind Heparan Sulfate at the Cell Surface
Open Access
- 15 May 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (10), 4918-4921
- https://doi.org/10.1128/jvi.75.10.4918-4921.2001
Abstract
Some echoviruses (EV) that bind decay-accelerating factor (DAF) also bind cells of human and murine origins in a DAF-independent manner. Pretreatment of cells with heparinase 1 or heparin blocks the binding of radiolabeled virus to the cell surface, and heparin prevents infection of rhabdomyosarcoma cells by certain EV, including several low-passage clinical isolates of EV 6 and some EV that do not bind DAF. These studies suggest that heparan sulfate may be of in vivo relevance as an attachment molecule for EV.Keywords
This publication has 60 references indexed in Scilit:
- Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotypeJournal of General Virology, 1999
- Analysis of the Steps Involved in Dengue Virus Entry into Host CellsVirology, 1999
- The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complexThe EMBO Journal, 1999
- Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.Journal of General Virology, 1998
- Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5Science, 1997
- Herpes Simplex Virus-1 Entry into Cells Mediated by a Novel Member of the TNF/NGF Receptor FamilyCell, 1996
- Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses.Proceedings of the National Academy of Sciences, 1994
- Cellular receptor for poliovirus: Molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamilyCell, 1989
- Molecular modeling of protein-glycosaminoglycan interactions.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.The Journal of Experimental Medicine, 1986